Evidence map›Paper›PMID 35170027›Full record

ArticleActa anaesthesiologica Scandinavica2022

Therapeutics and COVID-19-A living WHO guideline: Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine.

Morten H Møller, Michelle S Chew, Klaus T Olkkola, Marius Rehn, Arvi Yli-Hankala, Martin I Sigurðsson

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta anaesthesiologica Scandinavica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Morten H MøllerDepartment of Intensive Care, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0002-6378-9673
Michelle S ChewDepartment of Anaesthesia and Intensive Care, Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Klaus T OlkkolaDepartment of Anaesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Marius RehnDivision of Prehospital Services, Air Ambulance Department, Oslo University Hospital, Oslo, Norway.ORCID 0000-0001-9519-241X
Arvi Yli-HankalaDepartment of Anaesthesia, Tampere University Hospital, Tampere, Finland.ORCID 0000-0002-5029-9181
Martin I SigurðssonDivision of Anesthesia and Intensive Care Medicine, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.ORCID 0000-0001-7054-0844

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Clinical Practice Committee of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorses the Living WHO guideline on therapeutics and COVID-19. This trustworthy continuously updated guideline serves as a highly useful decision aid for Nordic anaesthesiologists caring for patients with COVID-19.

Indexed as

AnesthesiologyCOVID-19Critical CareHumansSocieties, MedicalWorld Health OrganizationAGREE IIclinical practice guidelineCOVID-19therapeuticsWHO

Identifiers

PMID35170027
PMCPMC9111142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.